Innovative Vaccine Approaches | EK50



Sessions

Study of SARS-CoV-2 adjuvanted by OMVs as a vaccine platform and future perspectives


Speaker(s):

Novel Bile Salt Stabilized Nano-Colloidal Carriers For Oral Vaccine Delivery


Speaker(s):

Stabilization of the SARS-CoV-2 Spike receptor-binding domain using deep mutational scanning and structure-based design


Speaker(s):

Moving beyond the titer paradigm: rational design of a next-gen glycoconjugate vaccine inducing highly functional antibodies


Speaker(s):

First recombinant dual-hit glycoconjugate vaccine production platform to combat Group A Streptococcus


Speaker(s):

Vaccine nanoparticles for elicitation of strong cellular and humoral immune responses.


Speaker(s):

Using synthetic biology to generate rapidly manufacturable hyper-stable vaccines


Speaker(s):

Design and immunogenicity of a Pan-SARS-CoV-2 synthetic DNA vaccine


Speaker(s):

Epitope identification of SARS-CoV-2 structural proteins using in silico approaches to obtain conserved rational immunogenic peptide


Speaker(s):

Potent neutralizing humoral and cellular responses induced by SARS-CoV-2 Spike protein – polymeric glyco-adjuvant conjugate


Speaker(s):